The Assessment of CD56 and CD117 Expressions at the Time of the Diagnosis in Multiple Myeloma Patients
Objective: The purpose of this study is to investigate the relationship between the CD56 and CD117 expressions and the clinical and laboratory findings in multiple myeloma (MM) patients. Materials and Methods: Analyses of multiparametric flow cytometry data obtained from the diagnostic bone marrow a...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Galenos Publishing House
2017-08-01
|
| Series: | Turkish Journal of Hematology |
| Subjects: | |
| Online Access: | https://jag.journalagent.com/z4/download_fulltext.asp?pdir=tjh&un=TJH-40225 |
| _version_ | 1828018399833227264 |
|---|---|
| author | Funda Ceran Mesude Falay Simten Dağdaş Gülsüm Özet |
| author_facet | Funda Ceran Mesude Falay Simten Dağdaş Gülsüm Özet |
| author_sort | Funda Ceran |
| collection | DOAJ |
| description | Objective: The purpose of this study is to investigate the relationship between the CD56 and CD117 expressions and the clinical and laboratory findings in multiple myeloma (MM) patients. Materials and Methods: Analyses of multiparametric flow cytometry data obtained from the diagnostic bone marrow aspirations of a total of 34 newly diagnosed MM patients were assessed retrospectively. CD56 and CD117 expressions of the patients were compared with their stages and clinical parameters. The staging was performed according to the International Staging System (ISS). Results: Of the patients, 58.8% had ISS stage 1-2 MM while 41.2% had stage 3 MM. The number of CD56-positive patients was 29, whereas the number of CD117-positive patients was 13. There was no statistical difference between the CD56 and CD117 expressions and extramedullary involvement and lytic bone lesions. The median beta-2 microglobulin level was higher in the CD117-negative group (p=0.047). CD56 and CD117 expression levels were found to be lower in advanced-stage patients than in early-stage ones (p=0.026 and p=0.017). The lactate dehydrogenase (LDH) levels were high in advanced-stage patients, and an inverse relationship was found between LDH level and CD117 expression. Conclusion: Our findings that the CD56 and CD117 expression levels are lower in advanced stages than earlier stages and that LDH level and CD117 expression have an inverse relationship in patients with newly diagnosed MM suggest that CD56 and CD117 expressions may be prognostic markers for MM. |
| first_indexed | 2024-04-10T11:04:20Z |
| format | Article |
| id | doaj.art-42e89e96e47e4cd58cf94b60aa6cd3e6 |
| institution | Directory Open Access Journal |
| issn | 1308-5263 |
| language | English |
| last_indexed | 2024-04-10T11:04:20Z |
| publishDate | 2017-08-01 |
| publisher | Galenos Publishing House |
| record_format | Article |
| series | Turkish Journal of Hematology |
| spelling | doaj.art-42e89e96e47e4cd58cf94b60aa6cd3e62023-02-15T16:19:31ZengGalenos Publishing HouseTurkish Journal of Hematology1308-52632017-08-0134322623210.4274/tjh.2016.0394TJH-40225The Assessment of CD56 and CD117 Expressions at the Time of the Diagnosis in Multiple Myeloma PatientsFunda Ceran0Mesude Falay1Simten Dağdaş2Gülsüm Özet3Ankara Numune Training and Research Hospital, Clinic of Hematology, Ankara, TurkeyAnkara Numune Training and Research Hospital, Clinic of Hematology, Ankara, TurkeyAnkara Numune Training and Research Hospital, Clinic of Hematology, Ankara, TurkeyAnkara Numune Training and Research Hospital, Clinic of Hematology, Ankara, TurkeyObjective: The purpose of this study is to investigate the relationship between the CD56 and CD117 expressions and the clinical and laboratory findings in multiple myeloma (MM) patients. Materials and Methods: Analyses of multiparametric flow cytometry data obtained from the diagnostic bone marrow aspirations of a total of 34 newly diagnosed MM patients were assessed retrospectively. CD56 and CD117 expressions of the patients were compared with their stages and clinical parameters. The staging was performed according to the International Staging System (ISS). Results: Of the patients, 58.8% had ISS stage 1-2 MM while 41.2% had stage 3 MM. The number of CD56-positive patients was 29, whereas the number of CD117-positive patients was 13. There was no statistical difference between the CD56 and CD117 expressions and extramedullary involvement and lytic bone lesions. The median beta-2 microglobulin level was higher in the CD117-negative group (p=0.047). CD56 and CD117 expression levels were found to be lower in advanced-stage patients than in early-stage ones (p=0.026 and p=0.017). The lactate dehydrogenase (LDH) levels were high in advanced-stage patients, and an inverse relationship was found between LDH level and CD117 expression. Conclusion: Our findings that the CD56 and CD117 expression levels are lower in advanced stages than earlier stages and that LDH level and CD117 expression have an inverse relationship in patients with newly diagnosed MM suggest that CD56 and CD117 expressions may be prognostic markers for MM.https://jag.journalagent.com/z4/download_fulltext.asp?pdir=tjh&un=TJH-40225cd56cd117flow cytometrymultiple myeloma |
| spellingShingle | Funda Ceran Mesude Falay Simten Dağdaş Gülsüm Özet The Assessment of CD56 and CD117 Expressions at the Time of the Diagnosis in Multiple Myeloma Patients Turkish Journal of Hematology cd56 cd117 flow cytometry multiple myeloma |
| title | The Assessment of CD56 and CD117 Expressions at the Time of the Diagnosis in Multiple Myeloma Patients |
| title_full | The Assessment of CD56 and CD117 Expressions at the Time of the Diagnosis in Multiple Myeloma Patients |
| title_fullStr | The Assessment of CD56 and CD117 Expressions at the Time of the Diagnosis in Multiple Myeloma Patients |
| title_full_unstemmed | The Assessment of CD56 and CD117 Expressions at the Time of the Diagnosis in Multiple Myeloma Patients |
| title_short | The Assessment of CD56 and CD117 Expressions at the Time of the Diagnosis in Multiple Myeloma Patients |
| title_sort | assessment of cd56 and cd117 expressions at the time of the diagnosis in multiple myeloma patients |
| topic | cd56 cd117 flow cytometry multiple myeloma |
| url | https://jag.journalagent.com/z4/download_fulltext.asp?pdir=tjh&un=TJH-40225 |
| work_keys_str_mv | AT fundaceran theassessmentofcd56andcd117expressionsatthetimeofthediagnosisinmultiplemyelomapatients AT mesudefalay theassessmentofcd56andcd117expressionsatthetimeofthediagnosisinmultiplemyelomapatients AT simtendagdas theassessmentofcd56andcd117expressionsatthetimeofthediagnosisinmultiplemyelomapatients AT gulsumozet theassessmentofcd56andcd117expressionsatthetimeofthediagnosisinmultiplemyelomapatients AT fundaceran assessmentofcd56andcd117expressionsatthetimeofthediagnosisinmultiplemyelomapatients AT mesudefalay assessmentofcd56andcd117expressionsatthetimeofthediagnosisinmultiplemyelomapatients AT simtendagdas assessmentofcd56andcd117expressionsatthetimeofthediagnosisinmultiplemyelomapatients AT gulsumozet assessmentofcd56andcd117expressionsatthetimeofthediagnosisinmultiplemyelomapatients |